Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Total Assets

Latest as of September 2025: CN¥8.59 Billion CNY ≈ $1.26 Billion USD

Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) holds total assets worth CN¥8.59 Billion CNY (≈ $1.26 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Guizhou Xinbang Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

Guizhou Xinbang Pharmaceutical Co Ltd - Total Assets Trend (2006–2024)

This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.

Guizhou Xinbang Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Guizhou Xinbang Pharmaceutical Co Ltd's total assets of CN¥8.59 Billion consist of 58.2% current assets and 41.8% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	11.3%
Accounts Receivable	CN¥3.01 Billion	33.3%
Inventory	CN¥1.06 Billion	11.8%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥189.54 Million	2.1%
Goodwill	CN¥603.75 Million	6.7%

Asset Composition Trend (2006–2024)

This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Guizhou Xinbang Pharmaceutical Co Ltd (002390) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guizhou Xinbang Pharmaceutical Co Ltd's current assets represent 58.2% of total assets in 2024, a decrease from 61.0% in 2006.
Cash Position: Cash and equivalents constituted 11.3% of total assets in 2024, down from 16.5% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 33.3% of total assets.

Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Guizhou Xinbang Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥16.53 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥10.21 Billion
Shandong Lukang Pharmaceutical Co Ltd SHG:600789	China	CN¥9.88 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	China	CN¥2.53 Billion

Guizhou Xinbang Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.57	2.92	1.36
Quick Ratio	2.90	2.40	1.17
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥3.55 Billion	CN¥3.38 Billion	CN¥1.62 Billion

Guizhou Xinbang Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guizhou Xinbang Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.95
Latest Market Cap to Assets Ratio	0.10
Asset Growth Rate (YoY)	-2.3%
Total Assets	CN¥9.03 Billion
Market Capitalization	$870.41 Million USD

Valuation Analysis

Below Book Valuation: The market values Guizhou Xinbang Pharmaceutical Co Ltd's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Guizhou Xinbang Pharmaceutical Co Ltd's assets decreased by 2.3% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual total assets of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥9.03 Billion ≈ $1.32 Billion	-2.34%
2023-12-31	CN¥9.24 Billion ≈ $1.35 Billion	-5.60%
2022-12-31	CN¥9.79 Billion ≈ $1.43 Billion	+1.71%
2021-12-31	CN¥9.63 Billion ≈ $1.41 Billion	-0.35%
2020-12-31	CN¥9.66 Billion ≈ $1.41 Billion	-7.27%
2019-12-31	CN¥10.42 Billion ≈ $1.52 Billion	-4.01%
2018-12-31	CN¥10.85 Billion ≈ $1.59 Billion	-9.21%
2017-12-31	CN¥11.95 Billion ≈ $1.75 Billion	+10.72%
2016-12-31	CN¥10.80 Billion ≈ $1.58 Billion	+65.98%
2015-12-31	CN¥6.50 Billion ≈ $951.87 Million	+24.54%
2014-12-31	CN¥5.22 Billion ≈ $764.33 Million	+251.35%
2013-12-31	CN¥1.49 Billion ≈ $217.54 Million	+11.39%
2012-12-31	CN¥1.33 Billion ≈ $195.30 Million	+7.32%
2011-12-31	CN¥1.24 Billion ≈ $181.97 Million	+10.49%
2010-12-31	CN¥1.13 Billion ≈ $164.70 Million	+139.29%
2009-12-31	CN¥470.35 Million ≈ $68.83 Million	+6.24%
2008-12-31	CN¥442.73 Million ≈ $64.79 Million	+13.21%
2007-12-31	CN¥391.07 Million ≈ $57.23 Million	+3.09%
2006-12-31	CN¥379.34 Million ≈ $55.51 Million	--

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic

Market Cap

$870.41 Million

CN¥5.95 Billion CNY

Market Cap Rank

#9820 Global

#2728 in China

Share Price

CN¥3.06

Change (1 day)

-3.16%

52-Week Range

CN¥2.98 - CN¥4.15

All Time High

CN¥14.40